MCID: VRL012
MIFTS: 49

Viral Meningitis

Categories: Infectious diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Viral Meningitis

MalaCards integrated aliases for Viral Meningitis:

Name: Viral Meningitis 12 3 14 69
Meningitis, Viral 42
Meningitis Viral 52

Classifications:



Summaries for Viral Meningitis

CDC : 3 EspaƱol: Meningitis viral

MalaCards based summary : Viral Meningitis, also known as meningitis, viral, is related to meningitis and mollaret meningitis. An important gene associated with Viral Meningitis is SERPINA1 (Serpin Family A Member 1), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Efavirenz and Lamivudine have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and bone, and related phenotypes are hematopoietic system and immune system

Wikipedia : 72 Viral meningitis is a type of meningitis due to a viral infection. It results in inflammation of the... more...

Related Diseases for Viral Meningitis

Diseases in the Meningitis family:

Viral Meningitis Chronic Meningitis
Bacterial Meningitis

Diseases related to Viral Meningitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 200)
id Related Disease Score Top Affiliating Genes
1 meningitis 11.4
2 mollaret meningitis 10.8
3 indian tick typhus 10.7 CCL5 IFNG
4 benign infantile focal epilepsy with midline spikes and wave during sleep 10.7 CCL5 IL16
5 oropharyngeal cancer, childhood 10.6 CCL5 IFNG
6 smarca4-deficient sarcoma of thorax 10.6 CCL5 IL6
7 idiopathic peripheral autonomic neuropathy 10.5 ADA SERPINA1
8 anencephaly and spina bifida x-linked 10.5 IL6 SERPINA1
9 lymphocytic choriomeningitis 10.5
10 renal tubular acidosis 10.4 CCL2 CCL5 IFNG
11 antigen-peptide-transporter 2 deficiency 10.4 CCL2 IL6
12 gerstmann syndrome 10.4 ADA IFNG
13 collagenopathy type 2 alpha 1 10.4 CRP IL6
14 fanconi syndrome 10.4 CCL5 CXCL10
15 crystal arthropathies 10.3 CRP IL6
16 shoulder impingement syndrome 10.3 CRP IL6
17 brachydactyly-distal symphalangism syndrome 10.3 CRP IL6
18 vulvar sarcoma 10.3 IL6 SERPINA1
19 lymphocytic colitis 10.3 IFNG IL6
20 dental pulp necrosis 10.3 CXCL10 IFNG
21 urethral gland abscess 10.3 ADA CRP
22 epstein-barr virus hepatitis 10.3 CRP IL6
23 x-linked dominant intellectual disability-epilepsy syndrome 10.3 CRP IL6
24 erythema elevatum diutinum 10.3 CRP IL6
25 myelitis 10.3 CCL5 IFNG IL6
26 heart sarcoma 10.3 CCL5 IFNG IL6
27 cataract congenital autosomal dominant 10.3 CRP IL6
28 gastric ulcer 10.3 CCL5 IFNG IL6
29 chickenpox 10.3 CCL2 CRP SERPINA1
30 stargardt macular degeneration absent or hypoplastic corpus callosum mental retardation and dysmorphic features 10.3 CCL2 CCL5 IL6
31 arthropathy 10.3 ADA CRP
32 chronic diarrhea due to guanylate cyclase 2c overactivity 10.2 CRP IL6
33 diffuse glomerulonephritis 10.2 CCL2 IFNG IL6
34 askin's tumor 10.2 ADA CCL2 IFNG
35 malignant gastric granular cell tumor 10.2 CRP IL6
36 psychologic dyspareunia 10.2 CCL5 CXCL10 IFNG
37 hidradenitis suppurativa 10.2 CCL5 CXCL8
38 rocky mountain spotted fever 10.2 CRP CXCL10
39 cytomegalovirus retinitis 10.2 CCL2 CXCL8
40 mycobacterium malmoense 10.2 CD14 CXCL8
41 nodular nonsuppurative panniculitis 10.2 CRP IL6
42 herpangina 10.2 IFNG IL6
43 flinders island spotted fever 10.1 CCL2 CXCL8
44 mycobacterium xenopi 10.1 CD14 CXCL8
45 hemangioma of spleen 10.1 CRP IFNG IL6
46 alternating exotropia 10.1 CCL2 CRP
47 multiple congenital anomalies mental retardation, growth failure and cleft lip palate 10.1 CRP IFNG IL6
48 central nervous system leiomyosarcoma 10.1 CRP IL6
49 polyarteritis nodosa 10.1 ADA CRP IFNG
50 cornea cancer 10.1 CRP IFNG IL6

Comorbidity relations with Viral Meningitis via Phenotypic Disease Network (PDN):


Acute Cystitis Hypertension, Essential

Graphical network of the top 20 diseases related to Viral Meningitis:



Diseases related to Viral Meningitis

Symptoms & Phenotypes for Viral Meningitis

MGI Mouse Phenotypes related to Viral Meningitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.56 ADA CCL5 CD14 CXCL10 IFNG IL16
2 immune system MP:0005387 9.32 ADA CCL2 CCL5 CD14 CRP CXCL10

Drugs & Therapeutics for Viral Meningitis

Drugs for Viral Meningitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 158)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Efavirenz Approved, Investigational Phase 4,Phase 2,Phase 3 154598-52-4 64139
2
Lamivudine Approved, Investigational Phase 4,Phase 2,Phase 3 134678-17-4 60825
3
Zidovudine Approved Phase 4 30516-87-1 35370
4
Stavudine Approved, Investigational Phase 4,Phase 2,Phase 3 3056-17-5 18283
5
Amphotericin B Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 1397-89-3 14956 5280965
6
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
7
Sulfamethoxazole Approved Phase 4 723-46-6 5329
8
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
9
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
10
leucovorin Approved, Nutraceutical Phase 4 58-05-9 143 6006
11 Anti-HIV Agents Phase 4,Phase 2,Phase 3
12 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1
13 Anti-Retroviral Agents Phase 4,Phase 2,Phase 3
14 Antiviral Agents Phase 4,Phase 2,Phase 3
15 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
16 Cytochrome P-450 CYP3A Inducers Phase 4,Phase 2,Phase 3
17 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
18 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3
19 Reverse Transcriptase Inhibitors Phase 4,Phase 2,Phase 3
20 Antibodies Phase 4,Phase 2
21 Immunoglobulins Phase 4,Phase 2
22 Vaccines Phase 4,Phase 3,Phase 2,Phase 1
23 Heptavalent Pneumococcal Conjugate Vaccine Phase 4,Phase 3,Phase 2
24 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1
25 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1
26 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1
27 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
28 Liposomal amphotericin B Phase 4,Phase 3,Phase 2,Phase 1
29 Antimalarials Phase 4
30 Folic Acid Antagonists Phase 4
31 Renal Agents Phase 4
32 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4
33 Vitamin B Complex Phase 4
34 Folate Nutraceutical Phase 4
35 Vitamin B9 Nutraceutical Phase 4
36
Ethambutol Approved Phase 2, Phase 3 74-55-5 3279 14052
37
Isoniazid Approved Phase 2, Phase 3 54-85-3 3767
38
Nevirapine Approved Phase 2, Phase 3 129618-40-2 4463
39
Pyrazinamide Approved Phase 2, Phase 3 98-96-4 1046
40
Rifampin Approved Phase 2, Phase 3 13292-46-1 5458213 5381226
41
Streptomycin Approved, Vet_approved Phase 2, Phase 3 57-92-1 19649
42
Fluconazole Approved Phase 3,Phase 2,Phase 1 86386-73-4 3365
43
Flucytosine Approved Phase 2, Phase 3 2022-85-7 3366
44
Sertraline Approved Phase 3 79617-96-2 68617
45
Lactitol Investigational Phase 3,Phase 2 585-86-4 3871
46 Antibiotics, Antitubercular Phase 2, Phase 3
47 Antimetabolites Phase 2, Phase 3
48 Antitubercular Agents Phase 2, Phase 3
49 Hypolipidemic Agents Phase 2, Phase 3
50 Lipid Regulating Agents Phase 2, Phase 3

Interventional clinical trials:

(show top 50) (show all 71)

id Name Status NCT ID Phase Drugs
1 Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali Completed NCT02286895 Phase 4
2 Cryptococcal Optimal ART Timing Trial Completed NCT01075152 Phase 4 efavirenz
3 Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection Completed NCT00371878 Phase 4
4 Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis Completed NCT00976040 Phase 4
5 Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Recruiting NCT03087890 Phase 4 Cotrimoxazole;Placebo
6 MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study Active, not recruiting NCT03226119 Phase 4
7 Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis Not yet recruiting NCT02686853 Phase 4 Liposomal amphotericin B
8 Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine Completed NCT01580033 Phase 3
9 Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children Completed NCT01428908 Phase 3
10 Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) Completed NCT00495326 Phase 2, Phase 3 Nevirapine based therapy;Efavirenz based therapy;Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z)
11 Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants Completed NCT00806195 Phase 3
12 A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Completed NCT01466387 Phase 3
13 Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS Completed NCT00001017 Phase 3 Fluconazole;Amphotericin B
14 Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers Completed NCT00483574 Phase 3
15 A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers Completed NCT00384397 Phase 3
16 Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants Completed NCT00161928 Phase 3
17 Cryptococcal Antigen Screening Plus Sertraline Recruiting NCT03002012 Phase 3 Sertraline;Placebo Oral Tablet;Fluconazole
18 Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa Active, not recruiting NCT01715922 Phase 2, Phase 3 Fluconazole;Flucytosine
19 Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers Active, not recruiting NCT03205371 Phase 3
20 Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) Completed NCT00310856 Phase 2
21 Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination Completed NCT01650389 Phase 2
22 Dexamethasone in Cryptococcal Meningitis Completed NCT00000776 Phase 2 Flucytosine;Fluconazole;Amphotericin B;Dexamethasone
23 High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals Completed NCT00885703 Phase 1, Phase 2 Fluconazole;Amphotericin B
24 Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis Completed NCT00012467 Phase 2 Itraconazole;Flucytosine;Fluconazole;Amphotericin B;Interferon gamma-1b
25 Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth Completed NCT00459316 Phase 1, Phase 2
26 Treatment With Tamoxifen in Cryptococcal Meningitis Not yet recruiting NCT03112031 Phase 2 Tamoxifen;Amphotericin B;Fluconazole
27 Treatment of West Nile Virus With MGAWN1 Terminated NCT00927953 Phase 2
28 Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children Completed NCT01406509 Phase 1
29 The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis Completed NCT00002316 Phase 1 Lobradimil;Amphotericin B
30 SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy Completed NCT00000677 Phase 1 SCH 39304
31 An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease Terminated NCT00091845 Phase 1 AVI-4020 Injection
32 Long Term Outcomes of EV71 CNS Infection Unknown status NCT00172393
33 Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis Unknown status NCT00433719 Combivir and efavirenz
34 Early Waning of Maternal Measles and Meningitis C Antibodies Unknown status NCT02219061
35 Diagnostic Performance of Clinical Signs Patients Suspected of Meningitis to Emergencies Completed NCT02841254
36 Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E. Completed NCT01396798
37 West Nile Virus Natural History Completed NCT00138463
38 Infection, Sepsis and Meningitis in Surinamese Neonates Completed NCT02486783
39 Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections Completed NCT01917461
40 Nervous System Infections Among Patients With Febrile Seizure Completed NCT01694524
41 Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care Completed NCT02024282
42 Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa Completed NCT00830856 Fluconazole;Fixed dose - Stavudine, lamivudine and Nevirapine;Fixed dose - Stavudine, Lamivudine, Nevirapine
43 A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS Completed NCT00002294 Fluconazole
44 Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome Completed NCT00002019 Amphotericin B, Lipid-based;Amphotericin B
45 Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome Completed NCT00002074 Fluconazole;Amphotericin B
46 Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis Completed NCT00000708 Flucytosine;Fluconazole;Amphotericin B
47 Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis Completed NCT00002010 Fluconazole
48 Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis Completed NCT00002076 Fluconazole
49 A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis Completed NCT00002305 Flucytosine;Fluconazole;Amphotericin B
50 Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis Completed NCT00002075 Flucytosine;Fluconazole;Amphotericin B

Search NIH Clinical Center for Viral Meningitis

Cochrane evidence based reviews: meningitis, viral

Genetic Tests for Viral Meningitis

Anatomical Context for Viral Meningitis

MalaCards organs/tissues related to Viral Meningitis:

39
Brain, Spinal Cord, Bone, Lung, T Cells, Neutrophil, Testes

Publications for Viral Meningitis

Articles related to Viral Meningitis:

(show top 50) (show all 160)
id Title Authors Year
1
Cerebrospinal fluid metabolomic profiling in tuberculous and viral meningitis: Screening potential markers for differential diagnosis. ( 28063937 )
2017
2
Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis: A cross-sectional study. ( 28858084 )
2017
3
Viral meningitis: current issues in diagnosis and treatment. ( 28118219 )
2017
4
Cerebrospinal fluid lactate: a differential biomarker for bacterial and viral meningitis in children. ( 28866321 )
2017
5
Etiological agents of viral meningitis in children from a dengue-endemic area, Southeast region of Brazil. ( 28320174 )
2017
6
With a little help from a computer: discriminating between bacterial and viral meningitis based on dominance-based rough set approach analysis. ( 28796045 )
2017
7
Predominance of enterovirus B and echovirus 30 as cause of viral meningitis in a UK population. ( 27367546 )
2016
8
Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study. ( 27527749 )
2016
9
Viral meningitis: epidemiology and diagnosis. ( 27527750 )
2016
10
The usefulness of serum delta neutrophil index for differentiating bacterial and viral meningitis in the emergency department. ( 27752624 )
2016
11
Cerebrospinal fluid ferritin and albumin index: potential candidates for scoring system to differentiate between bacterial and viral meningitis in children. ( 26999689 )
2016
12
Meningitis retention syndrome: An unusual complication of viral meningitis. ( 27841204 )
2016
13
Viral Meningitis Epidemics and a Single, Recent, Recombinant and Anthroponotic Origin of Swine Vesicular Disease Virus. ( 26508717 )
2015
14
Procalcitonin as a Serum Biomarker for Differentiation of Bacterial Meningitis From Viral Meningitis in Children: Evidence From a Meta-Analysis. ( 26378091 )
2015
15
Confirmed viral meningitis with normal CSF findings. ( 25035443 )
2014
16
Time trends of viral meningitis among young adults in Israel: 1978-2012. ( 24463724 )
2014
17
Molecular characterisation of enteroviruses and clinical findings from a cluster of paediatric viral meningitis cases in Tshwane, South Africa 2010-2011. ( 25176522 )
2014
18
Cerebral microbleeding in varicella-zoster viral meningitis: an early sign of vasculopathy? ( 24463624 )
2014
19
Restricted diffusion of the splenium of the corpus callosum in viral meningitis. ( 24707341 )
2014
20
Underreporting of viral encephalitis and viral meningitis, Ireland, 2005-2008. ( 23965781 )
2013
21
Herpes zoster as a cause of viral meningitis in immunocompetent patients. ( 23307457 )
2013
22
Viral meningitis and encephalitis. ( 23981453 )
2013
23
Trends in the management of viral meningitis at United States children's hospitals. ( 23530164 )
2013
24
Comparison of cytokine gene polymorphisms among Greek patients with invasive meningococcal disease or viral meningitis. ( 23378564 )
2013
25
Viral meningitis admitted to an infectious diseases hospital: a retrospective case series. ( 24340533 )
2013
26
Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi. ( 22798048 )
2013
27
Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008. ( 22336050 )
2012
28
Lumbar puncture is not needed for all patients suspected to have viral meningitis. ( 22340799 )
2012
29
Vogt-Koyanagi-Harada syndrome: a rare but important differential diagnosis of viral meningitis. ( 21905951 )
2012
30
Clinical prediction rule for differentiating tuberculous from viral meningitis. ( 22507645 )
2012
31
Impact of polymerase chain reaction results on patient management during a viral meningitis outbreak in Tropical North Queensland. ( 22313560 )
2012
32
Performance of thirteen clinical rules to distinguish bacterial and presumed viral meningitis in Vietnamese children. ( 23209715 )
2012
33
Viral meningitis: which patients can be discharged from the emergency department? ( 22709622 )
2012
34
Vertebral artery dissection associated with viral meningitis. ( 22909191 )
2012
35
Viral meningitis, active and reserve components, U.S. Armed Forces, 2002-2011. ( 22963254 )
2012
36
Acute bacterial and viral meningitis. ( 23221840 )
2012
37
A dural arteriovenous fistula in cavernous sinus developed from viral meningitis. ( 21748936 )
2011
38
Patient Education Series. Viral meningitis in adults. ( 21403505 )
2011
39
Descriptive analysis of viral meningitis in a general hospital: differences in the characteristics between children and adults. ( 21349608 )
2011
40
Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. ( 21292281 )
2011
41
Cytokine and adhesion molecule expression evolves between the neutrophilic and lymphocytic phases of viral meningitis. ( 20626298 )
2010
42
Secondary SUNCT syndrome caused by viral meningitis. ( 19444540 )
2009
43
Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. ( 19011611 )
2009
44
Nondominant hemisphere encephalitis in patient with signs of viral meningitis, New York, USA. ( 19751606 )
2009
45
CSF lactate level: a useful diagnostic tool to differentiate acute bacterial and viral meningitis. ( 19757692 )
2009
46
Viral meningitis. ( 18174598 )
2008
47
Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. ( 18680414 )
2008
48
Temporary divergence paralysis in viral meningitis. ( 18562842 )
2008
49
A new parameter in the differential diagnosis of bacterial and viral meningitis. ( 21063298 )
2008
50
Acute and recurrent viral meningitis. ( 18579020 )
2008

Variations for Viral Meningitis

Expression for Viral Meningitis

Search GEO for disease gene expression data for Viral Meningitis.

Pathways for Viral Meningitis

Pathways related to Viral Meningitis according to GeneCards Suite gene sharing:

(show all 41)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.79 CCL2 CCL5 CD14 CRP CXCL10 CXCL8
2
Show member pathways
13.54 CCL2 CCL5 CD14 CXCL10 CXCL8 IFNG
3
Show member pathways
13.43 CCL2 CCL5 CXCL8 IFNG IL16 IL6
4
Show member pathways
13.31 CCL2 CCL5 CXCL10 CXCL8 IL16 IL6
5
Show member pathways
13.25 CCL2 CCL5 CXCL10 CXCL8 IFNG IL16
6
Show member pathways
13.19 CCL2 CCL5 CXCL10 CXCL8 IL16 IL6
7
Show member pathways
12.89 CCL2 CCL5 CD14 CXCL8 IL6
8
Show member pathways
12.66 CCL5 CXCL10 CXCL8 IFNG IL6
9
Show member pathways
12.66 CCL2 CCL5 CXCL10 CXCL8 IFNG IL6
10
Show member pathways
12.64 CCL2 CCL5 CD14 CXCL10 CXCL8 IFNG
11
Show member pathways
12.51 CCL2 CD14 IFNG IL6
12 12.46 CCL2 CCL5 CXCL10 IFNG
13
Show member pathways
12.21 CD14 CXCL8 IFNG IL6
14
Show member pathways
12.21 CCL2 CXCL10 CXCL8 IFNG IL6
15
Show member pathways
12.09 CXCL8 IFNG IL16 IL6
16
Show member pathways
12.05 CD14 CXCL10 CXCL8 IFNG IL6
17
Show member pathways
11.96 CCL2 CCL5 CXCL10 CXCL8
18 11.93 CD14 IFNG IL6
19 11.91 CCL2 CXCL8 IL6
20 11.88 CCL2 CCL5 CXCL10 IL6
21 11.87 CXCL8 IFNG IL6
22 11.85 CCL2 CXCL10 CXCL8 IFNG IL6
23 11.84 CCL2 CXCL8 IL6
24 11.82 CD14 CXCL8 IFNG IL6
25
Show member pathways
11.81 CD14 CXCL8 IL6
26 11.75 CD14 CXCL8 IFNG IL6
27 11.74 CXCL8 IFNG IL6
28 11.7 CD14 CXCL8 IL6
29 11.7 CD14 IFNG IL6
30
Show member pathways
11.61 CXCL8 IFNG IL6
31 11.61 CCL2 CCL5 CXCL8 IFNG IL6
32 11.55 CXCL8 IFNG IL6
33 11.54 CD14 CXCL8 IL6
34 11.4 CCL2 CXCL8 IFNG IL6
35 11.3 CCL2 CXCL8 IL6
36 11.15 CCL2 CCL5 CXCL8 IL6 SERPINA1
37 11.13 CCL2 IFNG TIMP2
38 11.06 CCL5 CXCL8
39 10.98 CRP CXCL8 IL6
40 10.86 CCL2 CCL5 CXCL10 CXCL8 IL16 IL6
41 10.71 CCL2 CCL5 CXCL10 CXCL8 IL6

GO Terms for Viral Meningitis

Cellular components related to Viral Meningitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.7 CCL2 CCL5 CD14 CRP CXCL10 CXCL8
2 external side of plasma membrane GO:0009897 9.55 ADA CD14 CXCL10 IFNG IL6
3 extracellular space GO:0005615 9.4 ADA CCL2 CCL5 CD14 CRP CXCL10

Biological processes related to Viral Meningitis according to GeneCards Suite gene sharing:

(show all 47)
id Name GO ID Score Top Affiliating Genes
1 cell surface receptor signaling pathway GO:0007166 9.94 CCL2 CD14 CXCL10 IFNG
2 response to lipopolysaccharide GO:0032496 9.91 CCL2 CD14 CXCL10 IL6
3 aging GO:0007568 9.88 ADA CCL2 IL6 TIMP2
4 response to drug GO:0042493 9.88 ADA CCL2 IFNG IL6 TIMP2
5 response to virus GO:0009615 9.85 CCL5 CXCL10 IFNG
6 positive regulation of neuron differentiation GO:0045666 9.83 IFNG IL6 TIMP2
7 cell chemotaxis GO:0060326 9.81 CCL2 CCL5 CXCL10
8 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.81 CCL5 IFNG IL6
9 positive regulation of T cell proliferation GO:0042102 9.8 CCL5 IFNG IL6
10 response to cytokine GO:0034097 9.8 CCL5 IL6 TIMP2
11 humoral immune response GO:0006959 9.79 CCL2 IFNG IL6
12 response to heat GO:0009408 9.79 CCL2 CD14 IL6
13 positive regulation of tumor necrosis factor production GO:0032760 9.77 CCL2 CD14 IFNG
14 positive regulation of cell adhesion GO:0045785 9.77 CCL2 CCL5 IFNG
15 cellular response to tumor necrosis factor GO:0071356 9.76 CCL2 CCL5 CXCL8 IL6
16 monocyte chemotaxis GO:0002548 9.74 CCL2 CCL5 IL6
17 acute-phase response GO:0006953 9.72 CRP IL6 SERPINA1
18 response to bacterium GO:0009617 9.71 CCL2 CD14 IL6
19 cellular response to interleukin-1 GO:0071347 9.71 CCL2 CCL5 CXCL8 IL6
20 positive regulation of T cell activation GO:0050870 9.7 ADA CCL2
21 defense response to protozoan GO:0042832 9.7 IFNG IL6
22 lipopolysaccharide-mediated signaling pathway GO:0031663 9.7 CCL2 CCL5 CD14
23 immune response GO:0006955 9.7 CCL2 CCL5 CXCL10 CXCL8 IFNG IL16
24 positive regulation of JAK-STAT cascade GO:0046427 9.69 CCL5 IL6
25 embryonic digestive tract development GO:0048566 9.69 ADA CXCL8
26 positive regulation of T cell migration GO:2000406 9.69 CCL5 CXCL10
27 cellular response to fibroblast growth factor stimulus GO:0044344 9.69 CCL2 CCL5 CXCL8
28 positive regulation of macrophage chemotaxis GO:0010759 9.68 CCL2 CCL5
29 induction of positive chemotaxis GO:0050930 9.68 CXCL8 IL16
30 macrophage chemotaxis GO:0048246 9.68 CCL2 CCL5
31 response to molecule of bacterial origin GO:0002237 9.67 CD14 CXCL8
32 response to auditory stimulus GO:0010996 9.67 CXCL10 IL6
33 PERK-mediated unfolded protein response GO:0036499 9.67 CCL2 CXCL8
34 response to tumor necrosis factor GO:0034612 9.67 CCL2 CCL5 CD14
35 chemokine-mediated signaling pathway GO:0070098 9.67 CCL2 CCL5 CXCL10 CXCL8
36 negative regulation of G-protein coupled receptor protein signaling pathway GO:0045744 9.66 CCL5 CXCL8
37 positive regulation of protein import into nucleus, translocation GO:0033160 9.66 IFNG IL6
38 negative regulation of lipid storage GO:0010888 9.65 CRP IL6
39 neutrophil activation GO:0042119 9.65 CCL5 CXCL8
40 chemotaxis GO:0006935 9.65 CCL2 CCL5 CXCL10 CXCL8 IL16
41 neutrophil chemotaxis GO:0030593 9.62 CCL2 CCL5 CXCL8 IFNG
42 positive regulation of monocyte chemotaxis GO:0090026 9.61 CCL2 CCL5 CXCL10
43 regulation of vascular endothelial growth factor production GO:0010574 9.58 CCL2 IL6
44 neutrophil apoptotic process GO:0001781 9.56 IFNG IL6
45 inflammatory response GO:0006954 9.5 CCL2 CCL5 CD14 CRP CXCL10 CXCL8
46 cellular response to lipopolysaccharide GO:0071222 9.1 CCL2 CD14 CXCL10 CXCL8 IFNG IL6
47 negative regulation of cell proliferation GO:0008285 10 CXCL8 IFNG IL6 TIMP2

Molecular functions related to Viral Meningitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chemokine activity GO:0008009 9.26 CCL2 CCL5 CXCL10 CXCL8
2 cytokine activity GO:0005125 9.17 CCL2 CCL5 CXCL10 CXCL8 IFNG IL16

Sources for Viral Meningitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....